Anne R. Mason

• PhRMA

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

Read more

• HTA
• PhRMA
• Health Technology Assessment…

How is Quality of Life Measured for Health Technology Assessments?

Read more

• Amgen
• Australia
• Canada
• Economic Evaluation
• Health Policy and Regulation
• Japan
• Netherlands
• New Zealand
• Resource Allocation
• South Korea
• UK
• Health Care Systems
• Health Data and Statistics

Resource Allocation in Public Sector Programmes: Does the Value of a Life Differ Between Governmental Departments?

Read more

• Cancer
• Clinical Outcomes
• Oncology

Using QALYs in Cancer: Review of the Methodological Limitations

Read more

• Cancer
• HTA
• NICE
• Oncology
• Health Technology Assessment…

Assessment and Appraisal of Oncology Medicines: NICE’s Approach and International HTA Experience

Read more